Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 5
Journal homepage
1,701
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
,
Tomohiro HirosePfizer Japan Inc., Tokyo, Japan; Correspondence[email protected]
View further author information
,
Yutaka EndoPfizer Japan Inc., Tokyo, Japan; View further author information
,
Noriko SugiyamaPfizer Japan Inc., Tokyo, Japan; View further author information
,
Yuri FukumaPfizer Japan Inc., Tokyo, Japan; View further author information
,
Yosuke MorishimaPfizer Japan Inc., Tokyo, Japan; View further author information
,
Naonobu SugiyamaPfizer Japan Inc., Tokyo, Japan; View further author information
,
Noritoshi YoshiiPfizer Japan Inc., Tokyo, Japan; View further author information
,
Nobuyuki MiyasakaDepartment of Rheumatology, Tokyo Medical & Dental University, Tokyo, Japan; View further author information
&
Takao KoikeHokkaido Medical Center for Rheumatic Diseases, Sapporo, JapanView further author information
 show all
Pages 737-746 | Received 17 May 2018, Accepted 23 Jul 2018, Published online: 20 Sep 2018

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.